ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000258725.1	ABT-263 (navitoclax)	Esophageal cancer	0.027738589	Sensitive
ENSG00000258725.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.018757044	Sensitive